MabGenesis
Operator of a biopharmaceutical company intended to develop therapeutic monoclonal antibody drugs for humans and animals. The company specializes in discovering fully human and canine/feline therapeut...
Valuation
$0
Share Price
N/A
Total Raised
$8.8M
Last Round
N/A